Genomictree Inc.
228760
株式のランク
#19129
Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to... Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.
株価
$6.58
時価総額
$161.41M
変化（1日）
-0.63%
変化（1年）
-50.29%
国
KR
取引 Genomictree Inc. (228760)
カテゴリー
Healthcare
Genomictree Inc.（228760）の株式分割履歴
Genomictree Inc.株（シンボル：228760）は合計で0回の株式分割を実施しました。
最新の株式分割はOct 21, 2026に行われました。
Oct 21, 2026より前に購入された228760株は、現在0228760株に相当します。
最新の株式分割はOct 21, 2026に行われました。
Oct 21, 2026より前に購入された228760株は、現在0228760株に相当します。
株式分割一覧
| 年 | 株式分割 | 分割比率 | 累積分割比率 |
|---|---|---|---|
| 提供された日付のデータは十分ではありません。 | |||
類似企業または競合他社の株式分割
| 企業 | 株式分割の回数 | 累積分割比率 | 国 |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
